Increase of cardiodepressant activity in medium incubating the posterior pituitary lobe in situ during vagal nerve stimulation in rat

• Autorzy: Goraca A. , Traczyk W. Z.
• Języki publikacji: EN

Abstrakty

EN

Previous studies have indicated that there is a cardiodepressant factor in the medium incubating the posterior pituitary lobe in situ. The cardiodepressant activity of the medium incubating the posterior pituitary lobe before and during stimulation of the vagus nerves was tested on isolated auricles of the right heart atrium of a two-day-old rat. It was found that the medium incubating the posterior pituitary lobe collected before stimulation decreased the contraction rate of the auricle by 34%, while that collected during the intermittent stimulation of the central ends of the cut vagus nerves caused a decrease of the auricle contractions frequency by 52%. The addition of cholinergic, serotoninergic, histaminergic receptor blockers or prostaglandin synthetase into Ringer-Lock’s solution bathing the auricle has no effect on the changes of the contraction rate caused by the incubation medium.

Słowa kluczowe

EN

cardiodepressant factor; posterior pituitary lobe; afferent fibre; vagus nerve; heart atrium; auricle; cholinergic receptor

• Wydawca: -
• Czasopismo: Journal of Physiology and Pharmacology
• Rocznik: 1991
• Tom: 42
• Numer: 3
• Opis fizyczny: p.333-341,fig.,ref.

Twórcy

autor

Goraca A.

• Department of Physiology, Institute of Physiology and Biochemistry, Medical University of Lodz, Lindleya 3, 90-131 Lodz, Poland

autor

Traczyk W. Z.

• Department of Physiology, Institute of Physiology and Biochemistry, Medical University of Lodz, Lindleya 3, 90-131 Lodz, Poland

Bibliografia

• 1. Chang HC, Chia KF, Hsü CH, Lim RKS. Reflex secretion of the posterior pituitary elicited through the vagus. J Physiol (London) 1937; 90: 87P-89P.
• 2. Mills E, Wang SC. Liberation of antidiuretic hormone: location of ascending pathways. Am J Physiol 1964; 207: 1399-1404.
• 3. Mills E, Wang SC. Liberation of antidiuretic hormone: pharmacologic blocade of ascending pathways. Am J Physiol 1964; 207: 1405-1410.
• 4. Dybali REJ, Koizumi K. Electrical activity in the supraoptic and paraventricular nuclei associated with neurohypophysial hormone release. J Physiol (London) 1969; 201: 711-722.
• 5. Barker JL, Crayton JW, Nicoll RA. Antidromic and orthodromic responses of paraventricular and supraoptic neurosecretory cells. Brain Res 1971; 33: 353-366.
• 6. Pickford M. The inhibitory effect of acetylcholine on water diuresis in the dog and its pituitary transmission. J Physiol (London) 1939; 95: 226-238.
• 7. Pickford M. The action of acetylcholine in the supraoptic nucleus of the chloralosed dog. J Physiol (London) 1947; 106: 264-270.
• 8. Gosbee JL, Lederis K. In vivo release of antidiuretic hormone by direct application of acetylcholine or carbachol to the rat neurohypophysis. Can J Physiol Pharmacol 1972; 50: 618-620.
• 9. Gregg CM, Sladek CD. A compartmentalized organ-cultured hypothalamo-neurohypophyseal system for the study of vasopressin release. Neuroendocrinology 1984; 38: 397-402.
• 10. Sladek CD, Joynt RJ. Characterization of cholinergic control of vasopressin release by the organ cultured rat hypothalamo-neurohypophyseal system. Endocrinology 1979; 104: 659-663.
• 11. The Pharmacopeia of the United States of America, Sixteenth Revision, October 1, 1960; 851.
• 12. Worthington WC, Jr. Blood samples from the pituitary stalk of the rat: method of .collection and factors determining volume. Nature 1966; 210; 710-712.
• 13. Traczyk WZ. Vasopressin release from incubated in situ posterior pituitary lobe in rats. Bull Acad Pol Sci Ser Sci Biol 1972; 20: 351-356.
• 14. Cyrkowicz A, Traczyk WZ. Effect of intravenous and intracarotid injections of hypertonic fluids on the release of melanocyte-stimulating hormone from the rat posterior pituitary lobe incubated in situ, J Endocr 1975; 66: 85-91.
• 15. Gorąca A, Traczyk WZ, Konarzewska A. The influence of amino acids, vasopressin and oxytocin on spontaneous contraction of the right auricle of the right atrium of two-day-old rats in vitro, Acta Physiol Pol 1984; 35: 454-459.
• 16. Gorąca A, Tranda T, Traczyk WZ. Appearance of a cardiodepressant factor in the medium incubating in situ the posterior pituitary lobe of the rat. I. Isolation of active compound. Acta Physiol Pol 1984; 35: 460-468.
• 17. Gorąca A, Traczyk WZ. Appearance of a cardiodepressant factor in the medium incubating in situ the posterior pituitary lobe of the rat. II. Differentation from other active compounds. Acta Physiol Pol 1988; 39: 98-111.
• 18. Gregg CM. The compartmentalized hypothalamo-neurohypophyseal system. Evidence for a neurohypophyseal action of acetylcholine on vasopressin release. Neuroendocrinology 1985; 40: 423-429.
• 19. Emerson ТЕ, Jr. Effects of angiotensin, epinephrine, norepinephrine and vasopressin on venous return. Am J Physiol 1966; 210: 933-942.
• 20. Osborn JW, Jr, Skelton MM, Cowley AW, Jr. Hemodynamic effects of vasopressin compared with angiotensin II in conscious rats. Am J Physiol 1987; 252: H628- H637.
• 21. Boyle WA, Segel LD. Direct cardiac effects of vasopressin and their reversal by a vascular antagonist. Am J Physiol 1986; 251: H734-H741.
• 22. Lefer AM, Inge TF, Jr. Differentation of a myocardial depressant factor present in shock plasma from known plasma peptides and salts. Proc Soc Exp Biol Med 1973; 142: 429-433.
• 23. Lederis K, Livingston A. Acetylcholine and related enzymes in the neural lobe and anterior hypothalamus of the rabbit. J Physiol (London) 1969; 201: 695-709.
• 24. Trendelenburg U. The action of histamine and 5-hydroxytryptamine on isolated mammalian atria. J Pharmacol Exp Ther 1960; 130: 450-460.
• 25. Laher I, McNeill JH. Effects of histamine on rat isolated atria. Can J Physiol Pharmacol 1980; 58: 1114-1116.
• 26. Shaffer JE, Malik KU. Mechanism of action of arachidonic acid in the isolated perfused rat heart. Can J Physiol Pharmacol 1984; 62: 551-558.
• 27. Gordon DB. Basis of the depressor action of adenosine phosphate. Am J Physiol 1961; 201: 1126-1130.
• 28. Gordon DB, Hesse DH. Blood pressure lowering action of adenosine diphosphate and related compounds. Am J JPlvysiol 1961; 201: 1123-1125.
• 29. Schally AV, Kastin AJ, Barrett JF, Carter WH, Bowers CY, White WF. On vasodepressor activity in the hypothalamus. Biochem Pharmacol 1966; 15: 1805-1811.
• 30. Krause EG, Halle W, Wollenberger A. Effect of dibutyryl cyclic GMP on culture beating rat heart cells. In: Advances in Cyclic Nucleotide Research, Vol. 1. Physiology and Pharmacology of cyclic AMP, edited by P. Greengard R. Paoletti and GA Robison, Baven Press, New York, 1972; 301-305.
• 31. Brand ED, Lefer AM. Myocardial depressant factor in plasma from cats in irreversible post-oligemic shock. Proc Soc Exp Biol Med 1966; 122: 200-203.
• 32. Lefer AM, Martin J. Origin of myocardial depressant factor in shock. Am J Physiol 1970; 218: 1423-1427.
• 33. Lefer AM. Role of a myocardial depressant factor in the pathogenesis of circulatory shock. Fed Proc 1970; 29: 1836-1847.
• 34. Lefer, AM. Interaction between myocardial depressant factor and vasoactive mediators with ischemia and shock. Am J Physiol 1987; 252: R193-R205.
• 35. de Bold A J, Borenstein HB, Veress AT, Sonnenberg H. A rapid and potent natriuretic response to intravenous injections of atrial myocardial extract in rats. Life Sci 1981; 28: 89-94.
• 36. Hiwatari M, Satoh K, Angus JA, Johnston CI. No effect of atrial natriuretic factor on cardiac rate, force and transmitter release. Clin Exp Pharmacol Physiol 1986; 13: 163-168.